drugset / Trial / NCT05157100
Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia
NaSingle-groupOpen-labelTreatment
Summary
Study of Ingrezza (Valbenazine) for the treatment of cervical dystonia.
Timeline
- Start
- 2021-10-19
- Primary completion
- 2023-09-15
- Completion
- 2023-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Valbenazine | Small molecule | 40 mg | Oral |
| Subject | Valbenazine | Small molecule | 80 mg | Oral |